Diagnosing and Treating Immune Thrombocytopenic Purpura
The group continues their analysis of emergencies by exploring their first hematologic emergency: Immune thrombocytopenic purpura (ITP). They explain how to confirm that the diagnosis is in fact ITP, and subsequently, provide a treatment plan.
Survival Outcomes of Neoadjuvant mFOLFIRINOX for Resectable PDAC
Officials Provide Update on Phase 2 Trial of THIO Plus Cemiplimab in NSCLC
Examining the Lifetime Risk of Gastric Cancer in Patients With CDH1 Gene Variants